Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quantum Value Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹161.22 |
| 26 Aug 2009 | ₹152.96 |
| 08 May 2011 | ₹214.09 |
| 17 Jan 2013 | ₹254.62 |
| 30 Sep 2014 | ₹359.09 |
| 11 Jun 2016 | ₹404.76 |
| 21 Feb 2018 | ₹516.62 |
| 04 Nov 2019 | ₹525.36 |
| 16 Jul 2021 | ₹727.89 |
| 28 Mar 2023 | ₹746.55 |
| 08 Dec 2024 | ₹1295.53 |
| 20 Aug 2026 | ₹1228.18 |
| Metric | Quantum · Direct · IDCW NAV ₹126.38 Very High risk ★★★★☆ | Category median Value Fund · 27 funds |
|---|---|---|
| -4.32% | +2.79% | |
| +11.56% | +12.68% | |
| +10.84% | +11.98% | |
| +10.69% | +10.69% | |
| +13.10% | +11.75% | |
| +9.45% | — | |
| +14.56% | +13.57% | |
| +13.84% | +12.46% | |
| +13.43% | +12.08% | |
| Risk | ||
| 12.32% | 14.87% | |
| 0.41 | 0.40 | |
| 0.57 | 0.54 | |
| -53.87% | -37.93% | |
| Nifty 500 | — | |
| +0.43% | +0.85% | |
| 0.84 | 0.95 | |
| 84.3% | 102.9% | |
| 74.7% | 102.9% | |
| 1.14% | 1.20% | |
| ₹1,107Cr | ₹1,405Cr | |
| Up to 2.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 4% | 40% | |
| Christy Mathai | — | |
| 03 Apr 2006 | — | |
| 31 | — | |
| 44.6% | — | |
| 6.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.